Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Yonghe Medical Group Co's ROE % for the quarter that ended in Jun. 2026 was 19.22%. Yonghe Medical Group Co's PB Ratio for the quarter that ended in Jun. 2026 was 1.07.
Yonghe Medical Group Co's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2026 was 17.96%.
Yonghe Medical Group Co ROE % Adjusted to Book Value Related Terms
Yonghe Medical Group Co ROE % Adjusted to Book Value Historical Data
* Premium members only.
The historical data trend for Yonghe Medical Group Co's ROE % Adjusted to Book Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Yonghe Medical Group Co ROE % Adjusted to Book Value Chart
STU:L97 vs HCA, THC, DVA: ROE % Adjusted to Book Value Comparison
For the Medical Care Facilities subindustry, Yonghe Medical Group Co's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Yonghe Medical Group Co ROE % Adjusted to Book Value vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Yonghe Medical Group Co's ROE % Adjusted to Book Value distribution charts can be found below:
* The bar in red indicates where Yonghe Medical Group Co's ROE % Adjusted to Book Value falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROE % Adjusted to Book Value of 17.96% mean?
Yonghe Medical Group Co (STU:L97) has a ROE % Adjusted to Book Value of 17.96% as of Jun. 2026. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Yonghe Medical Group Co and its competitors.
Is Yonghe Medical Group Co's ROE % Adjusted to Book Value too high?
Yonghe Medical Group Co's current ROE % Adjusted to Book Value is 17.96%. Overall, Yonghe Medical Group Co has a GF Score™ of 84/100, reflecting its overall financial health beyond just this single metric.
How does Yonghe Medical Group Co's ROE % Adjusted to Book Value compare to HCA and THC?
Yonghe Medical Group Co's ROE % Adjusted to Book Value of 17.96% can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Healthcare Providers & Services company?
A good ROE % Adjusted to Book Value depends on the Healthcare Providers & Services industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Yonghe Medical Group Co and its competitors. Yonghe Medical Group Co's current ROE % Adjusted to Book Value is 17.96%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Yonghe Medical Group Co stock overvalued right now?
Yonghe Medical Group Co (STU:L97) has a current ROE % Adjusted to Book Value of 17.96%. The stock's GF Value™ is €0.20, compared to a current price of €0.25 — trading 26% above its estimated fair value. The current ROE % Adjusted to Book Value is 17.96%. Yonghe Medical Group Co's overall GF Score™ is 84/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Yonghe Medical Group Co (STU:L97), the current ROE % Adjusted to Book Value is 17.96% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Yonghe Medical Group Co (STU:L97) Overvalued in 2026?
Based on GuruFocus' analysis, Yonghe Medical Group Co stock appears to be overvalued.
The current stock price of €0.25 is trading 26% above its estimated GF Value™ of €0.20.
Key valuation signals for STU:L97:
ROE % Adjusted to Book Value: 17.96%
GF Value™: €0.20 vs. price of €0.25 (26% above fair value)
No single metric tells the full story. See the STU:L97 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Yonghe Medical Group Co Ltd is a medical group in China that specializes in providing hair-related healthcare services. The company is principally engaged in the provision of hair transplant services. The company generated the majority of its revenue from hair transplant services. The company offers one-stop hair-related healthcare services covering hair transplants, medical hair care, routine hair restoration, and other ancillary services.
84GF Score
Get the complete analysis for STU:L97
ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:L97 has been successfully added to your 
